Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-24-029609

Chief Medical Officer sold 9,921 shares at an average $25.86 ($256,585)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Farwell Wildon · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-07 Sale : show line 1 in the form 10b5-1 −8,364 $25.80 $215,791 154,732 D
2024-03-07 Sale : show line 2 in the form 10b5-1 −1,557 $26.20 $40,793 153,175 D
Open-market sales · 9,921 sh · avg $25.86 · $256,585
Loading xslF345X05/ownership.xml…